PT  - JOURNAL ARTICLE
AU  - Chen, Yifan
AU  - Wang, Yueye
AU  - Shang, Xianwen
AU  - Wang, Wei
AU  - Zhu, Zhuoting
TI  - Association of Age-Related Macular Degeneration With Mortality: A Propensity Score-Matched Analysis
AID  - 10.1101/2022.01.18.22269511
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.01.18.22269511
4099  - http://medrxiv.org/content/early/2022/01/21/2022.01.18.22269511.short
4100  - http://medrxiv.org/content/early/2022/01/21/2022.01.18.22269511.full
AB  - Purpose To investigate the association between age-related macular degeneration (AMD) and 10-year all-cause and cause-specific mortality using a large-scale population-based sample.Methods Data from the 2005-2008 cycles of the National Health and Nutrition Examination Survey were used to assess the risk of mortality in relation to AMD in a propensity score-matched cohort. AMD status was assessed by retinal images with the standardized grading scheme. Mortality data until 31st December 2015 were derived from mortality archives. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for survival.Results A total of 4691 participants were included. After a median follow-up of 8.42 (IQR: 7.58-9.67) years, 698 participants died. Participants with any AMD had an increased risk of all-cause mortality (HR, 2.02; 95% CI, 1.37-2.98). Similar results were observed for early (HR, 1.93; 95% CI, 1.31-2.85) and late AMD (HR, 4.29; 95% CI, 2.10-8.79). For cause-specific mortality, any (HR, 2.17; 95% CI, 1.39-3.39), early (HR, 2.18; 95% CI, 1.36-3.51), and late AMD (HR, 3.95; 95% CI, 1.65-9.46) were associated with significantly higher mortality due to causes other than cardiovascular disease (CVD) or cancer. Late AMD independently predicted a higher risk of CVD mortality (HR, 2.48; 95% CI, 1.32-4.65).Conclusions The current study showed that any, early, and late AMD were associated with increased risks of all-cause mortality and mortality due to causes other than CVD or cancer. In addition, we found that late AMD was associated with increased risks of CVD mortality.Synopsis Late macular degeneration independently predicted higher cardiovascular disease mortality. Any, early and late age-related macular degeneration were associated with higher all-cause mortality and mortality due to causes other than cardiovascular disease or cancer.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe present work was supported by the Fundamental Research Funds of the State Key Laboratory of Ophthalmology, National Natural Science Foundation of China (82000901, 82101173), Project of Investigation on Health Status of Employees in Financial Industry in Guangzhou, China (Z012014075), Science and Technology Program of Guangzhou, China (202002020049), the Research Foundation of Medical Science and Technology of Guangdong Province (B2021237). The sponsor or funding organization had no role in the design or conduct of this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves only openly available human data, which can be obtained from: https://wwwn.cdc.gov/nchs/nhanes/default.aspxI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://wwwn.cdc.gov/nchs/nhanes/default.aspx AMDage-related macular degenerationanti-VEGFanti-vascular endothelial growth factorNHANESNational Health and Nutrition Examination SurveyNCHSNational Center for Health StatisticsICD-10International Statistical Classification of Diseases and Related Health Problems, Tenth RevisionHRHazard ratiosCIconfidence interval